// App-Quantinova.ai

TP1257 : Development of a total antigenicity IgG ELISA for the quality control of a mixed grass allergoid drug product

Researchers

Presenter

  • Starchenka S

Principal Investigators

  • Heath

  • Packer D

  • Kluklinska - Pijanka AM

  • Hewings S

  • Skinner MA

Medical Centers

  • Allergy Therapeutics Ltd, Worthing, United Kingdom

  • INDOOR Biotechnologies, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Collagen type IV alpha 2 chain

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved